Saama Technologies

What it does

Saama Technologies is an AI-native clinical analytics company that helps pharmaceutical companies and CROs accelerate drug development through intelligent analysis of clinical trial data. AI capabilities include AI-powered risk-based monitoring that identifies high-risk clinical trial sites and data issues for targeted oversight, ML safety signal detection that surfaces emerging adverse event patterns across trial populations, intelligent data quality management that flags inconsistencies and protocol deviations automatically, AI patient recruitment analytics that identify which sites and patient populations enroll fastest, regulatory submission intelligence that organizes and summarizes clinical data for FDA and EMA submissions, and clinical operations analytics that surface enrollment, timeline, and cost performance across trial portfolios.

Strengths

• Large pharmaceutical companies and CROs use Saama for AI clinical trial intelligence - ML monitoring reducing the cost of clinical oversight and AI safety analytics accelerating adverse event identification.
• Saama Technologies is an AI-native clinical analytics company that helps pharmaceutical companies and CROs accelerate drug development through intelligent analysis of clinical trial data.
• AI capabilities include AI-powered risk-based monitoring that identifies high-risk clinical trial sites and data issues for targeted oversight, ML safety signal detection that surfaces emerging adverse event patterns across trial populations, intelligent data quality management that flags inconsistencies and protocol deviations automatically, AI patient recruitment analytics that identify which sites and patient populations enroll fastest, regulatory submission intelligence that organizes and summarizes clinical data for FDA and EMA submissions, and clinical operations analytics that surface enrollment, timeline, and cost performance across trial portfolios.

Watch-outs

• Clinical trial analytics specialty: Saama is purpose-built for pharmaceutical clinical trial operations — general healthcare analytics, commercial pharma, and non-clinical life sciences have different requirements.
• Integration with clinical data management systems required: Saama's AI analytics require integration with EDC, CTMS, and safety databases — organizations must invest in data connectivity before AI analytics deliver clinical trial intelligence.
• Competes with IQVIA and Medidata for clinical analytics market: IQVIA and Medidata (Dassault Systèmes) offer competing clinical analytics capabilities — pharmaceutical buyers should compare AI analytical depth, system integration breadth, and implementation track record.

Pricing

Saama enterprise contracts through pharmaceutical partnerships. Not published. Annual contracts.